# Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy

> **NCT00625872** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 23 (actual)

## Conditions studied

- Growth Hormone Therapy
- Infant, Small for Gestational Age

## Interventions

- **DRUG:** Somatropin
- **DRUG:** Somatropin

## Key facts

- **NCT ID:** NCT00625872
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** The study terminated on 19-Jan-2011 due to insufficient recruitment of patients. No safety reasons contributed to the termination of the study.
- **Last updated:** 2012-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00625872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00625872, "Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00625872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*